At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
VelaShape III +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study to Evaluate VelaShape III & UltraShape Power Combined Treatment for Thigh Circumference Reduction
In Brief
A clinical study evaluating VelaShape III and UltraShape Power for Circumference Reduction. Completed, enrolled 16 participants across 1 site.
Detailed Summary
Prospective, one-arm, baseline-controlled pilot study for the evaluation of the VelaShape III combined with UltraShape Power treatment for non-invasive circumference reduction to the thighs.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCircumference Reduction
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartFeb 2018
Primary CompletionMay 2019
Study CompletionJul 2019
TodayJul 2026
First PostedFeb 12, 2018
Enrollment StartFeb 19, 2018
Primary CompletionMay 30, 2019
Study CompletionJul 3, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.4 years ago
Interventions
VelaShape IIIdevice
The VelaShape III device combines controlled infrared (IR) light and conducted bipolar radiofrequency (RF) energies with vacuum.
UltraShape Powerdevice
The UltraShape Power device uses focused ultrasound energy for lipolysis (breakdown of fat) via a non-thermal mechanism of action.